This article has been updated from a previous version to include comments made by Qiagen CEO Peer Schatz during an earnings call.

NEW YORK (GenomeWeb) – Qiagen reported after the close of the market on Monday that its third quarter revenues grew 4 percent year over year.

For the three months ended Sept. 30, Qiagen posted revenues of $377.9 million compared to $364.0 million a year ago, falling short of the consensus Wall Street estimate of $381.1 million. On an adjusted basis and at constant exchange rates (CER), Q3 revenues rose nearly 7 percent.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The New York Times Magazine writes that proteomics might be better poised than genomics to say when someone is falling ill.

Bloomberg profiles IndieBio, a startup incubator for the life sciences.

In an editorial, Nature calls for the end to the exploitation of foreign postdocs.

In Nucleic Acids Research this week: collection of epigenome-wide association study data, updated BloodSpot database, and more.